Genprex (GNPX) Shares Surge Ahead Of Prominent Convention
Genprex, Inc. (NASDAQ: GNPX) is witnessing a notable uptick in its shares following the declaration of its participation in a significant event. GNPX stock is currently experiencing a 17.76% increase, reaching $2.85 as observed in the latest market session. Presentation At 2024 BIO International Convention Ryan Confer, the President, Chief Financial Officer, and Chief Executive […]
Genprex, Inc. (GNPX) Stock Rocketing Higher in Aftermarket, Here’s the Reason
Genprex, Inc. (GNPX), a clinical-stage gene therapy company, has surged 18% in aftermarket trading session. As a result, GNPX stock is trading at $4.13 at the time of the writing. On Monday, GNPX stock closed the day at $3.50 after rocketing 167.18% during the regular trading session. The boom in the stock price could be […]
